pharma leaders
May-June 2012
CSR leadership

HOTEL LALIT ASHOK,
22nd OCTOBER,
BANGALORE, INDIA

Editorial Guidelines for Authors

Pharma Leadersis read by pharma professionals and executives. Therefore, we expect the focus of the articles to be relevant for them. The following guidelines aim to help you write the article(s) to meet our selection criteria.

Key Selection Criterion for Articles

We expect the article to be informative and relevant to the industry and focus on contemporary / futuristic topics. They should be written to deliver learning value to offer new insights to our readers.

Writing Style Suggestions

  • Please note that our in-house style is based on British English
  • We recommend the use of active voice and third person narrative. It will be of help if you can avoid the use of first- and second-person pronouns (I, we, you)
  • Provide short titles for the article and subheads
  • Use simple and uncomplicated language as far as possible
  • Please ensure that clarity is maintained throughout the article. Avoid sentences that are ambiguous or circumlocutory
  • To make the article easy to comprehend, see that all the supplementary information related to the article is provided in user-friendly formats (e.g. Tables, figures, charts etc.)
  • To make the article more interesting and easy to read, important or auxiliary information could be placed separately in sidebars or boxes
  • We do not publish references in the print version. Hence, we advise you to minimise the number of in-text references in the article. However, we do publish references in the magazine's online version (HTML)
  • Avoid clichés and jargon to the extent possible. Please provide explanations and definitions for the technical terms used to ensure clarity

Dos and Don'ts

  • Article(s) could focus on innovative / cutting-edge technologies and also experiences of the industry's leading organisations in areas such as best practices etc.
  • The articles that differentiate themselves by offering new insights or share experiences with a larger audience will be given priority. To provide learning value to our readership, articles based on the original research, innovation and/or any new aspect of the industry will be preferred
  • Articles should be free from copyright infringements and plagiarism. Authors will need to acknowledge all the relevant sources on which their article is based
  • Please provide proper acknowledgements for data, images and tables taken from other relevant sources with permissions wherever applicable
  • All articles undergo a multi-stage review process during which, the author(s) will be informed whether the article has been accepted, rejected or needs revision. The editorial team could suggest improvements to the article on a case-by-case basis
  • The articles written to promote the products or services of the author's company (unless they represent a breakthrough / innovation in the industry) are considered for publication as advertorials and attract relevant tariff

Guidelines to Authors

  • Papers are accepted for publication on the clear understanding
  • That they have neither been published nor being considered for publication elsewhere. All the authors should sign a certificate to this effect in respect of each article sent for publication. Covering letter should indicate the names, qualification and full address of all the authors.
  • That the research work has been carried out with the approval of the Institutional Ethics committee and as per the laws in force at the time of carrying out the work and at the time of sending the paper for publication in the country in which the research work was carried out. A certificate to this effect should be signed by all the authors. Authors should get written permission from concerned authorities for publication of articles on emerging and exotic diseases.
  • All the authors are jointly and severally responsible to the various authorities for the contents of the articles. Neither the Editor nor publisher hold themselves responsible in any manner whatsoever to the contents of the article and the views and interpretation expressed by the author in the article.
  • Authors should clearly indicate whether the article is a new or revised or copy of the article already sent. The letter should also furnish complete postal address and e-mail id. of the corresponding author. Article should be typed in A4 size paper in double space, following the format of the Pharma Leaders. Two copies should be sent to the Editor, Pharma Leaders.
  • The decision of the Editor shall be final in all matters pertaining to publication of papers. Editor has the right to do editorial revision of accepted paper with reference to the number of pages, tables and figures before publication if considered necessary. No reason shall be given for non-acceptance of the article. The copyright shall rest with the journal and no part of any paper can be reproduced without the specific permission of the Editor.
  • Receipt of the articles will be acknowledged with the registration number. The author should return the comments of the referees and original article along with two copies of revised articles. When articles are accepted for publication, acceptance letter would be sent from the editorial team.

Pharma Leaders Format

  • Title
  • Author/Authors name/names
  • Place of work (full address with pin code)
  • General Article : Brief Introduction (without heading), Materials and Methods, Results and Discussion , Summary, Acknowledgement (Optional) and References. (Not to exceed 6 pages)
  • Clinical Article: Brief introduction (without heading), Case history and Observations, Treatment and Discussion, Summary, Acknowledgement(Optional) References. (Not to exceed 4 pages)
  • hort Communication: Brief introduction (without heading), Materials and methods, Results and Discussion, Acknowledgment (Optional) References. (Not to exceed 3 pages)
  • Citing References.: In the text, references should be cited by the names of the authors followed by the year of publication in parenthesis. If more than two authors are there, the name of the first author followed by et al. should be used. If within the same section of the article, the reference is repeated, instead of the year loc.cit. should be used within the parenthesis. List of References furnished at the end of the article, should be arranged alphabetically. The author's name should be followed by the initials and before the last author 'and' should be used. The year of publication should be cited with parenthesis. The journal name with approved abbreviation should be in italics, the volume number should be in bold letter and the starting page number should be given after a colon and followed by a full stop.
  • The page limit is inclusive of tables and references.